Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Valneva Lyme Vaccine Candidate VLA15 Demonstrates Strong Anamnestic Response And Favorable Safety Profile After Third Yearly Booster Dose

Author: Benzinga Newsdesk | September 03, 2025 02:14am

Strong immune response after third yearly booster dose in children and adults
Significant anamnestic antibody response across all six serotypes
No safety concerns observed in any age group by independent Data Monitoring Committee (DMC), consistent with previous booster results.

Posted In: VALN